![Craig C. Estwick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig C. Estwick
Chairman at Nexpep Pty Ltd.
Craig C. Estwick active positions
Companies | Position | Start | End |
---|---|---|---|
Nexpep Pty Ltd. | Chairman | 01/01/2009 | - |
Career history of Craig C. Estwick
Former positions of Craig C. Estwick
Companies | Position | Start | End |
---|---|---|---|
Deloitte Consulting Pty Ltd.
![]() Deloitte Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Consulting Pty Ltd. provides cyber security consulting services. The company is based in Sydney, Australia. | Corporate Officer/Principal | - | 01/01/2000 |
ImmusanT, Inc.
![]() ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Training of Craig C. Estwick
The University of Queensland | Graduate Degree |
Statistics
International
Australia | 4 |
United States | 2 |
Operational
Director/Board Member | 1 |
Graduate Degree | 1 |
Chairman | 1 |
Sectoral
Consumer Services | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Nexpep Pty Ltd. | |
ImmusanT, Inc.
![]() ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Deloitte Consulting Pty Ltd.
![]() Deloitte Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Consulting Pty Ltd. provides cyber security consulting services. The company is based in Sydney, Australia. | Commercial Services |
- Stock Market
- Insiders
- Craig C. Estwick
- Experience